Related Experiment Video
Updated: Jul 15, 2026

08:27
Real-time Cytotoxicity Assays in Human Whole Blood
Published on: November 7, 2014
Cytotoxic drug: towards safer chemotherapy practices
1Prescription Audit Department, Indraprastha Apollo Hospital, Delhi Mathura Road, Sarita Vihar, New Delhi - 110 076, India. drjoshimukesh@rediffmail.com
Indian Journal of Cancer
|April 3, 2007
Summary
Healthcare lags in error reduction. This article outlines standards for safe cancer chemotherapy handling, including drug spillage and waste disposal, crucial for patient and staff safety.
Area of Science:
- Oncology
- Healthcare Management
- Patient Safety
Background:
- Healthcare industry faces significant challenges in error reduction, lagging behind other sectors.
- Medication errors pose risks, with anticancer drugs requiring special precautions due to their hazardous properties (mutagenic, teratogenic, carcinogenic).
Purpose of the Study:
- To establish standards for the safe use of cancer chemotherapy in hospital settings.
- To provide guidelines for managing drug spillages and disposing of chemotherapy waste.
- To benefit hospitals lacking defined standard operating procedures for chemotherapy administration.
Main Methods:
- Information compiled from cited references.
- Data gathered from reputable websites including The American Cancer Society and cancersourceRN.com.
Main Results:
- Identified critical areas for standardizing chemotherapy use: storage, dilution, administration, and waste disposal.
- Highlighted the necessity of specific protocols for handling anticancer drugs due to their hazardous nature.
Conclusions:
- Implementing defined standards for cancer chemotherapy is essential for minimizing medication errors and ensuring safety.
- Clear procedures for drug spillage and waste disposal are vital components of safe chemotherapy practices in hospitals.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.